Sokol L - Search Results

1

Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening.

Kiss R, Polgár T, Kirabo A, Sayyah J, Figueroa NC, List AF, Sokol L, Zuckerman KS, Gali M, Bisht KS, Sayeski PP, Keseru GM. Kiss R, et al. Among authors: sokol l. Bioorg Med Chem Lett. 2009 Jul 1;19(13):3598-601. doi: 10.1016/j.bmcl.2009.04.138. Epub 2009 May 5. Bioorg Med Chem Lett. 2009. PMID: 19447617 Free PMC article.

2

Immunomodulatory therapy for myelodysplastic syndromes.

Sokol L, List AF. Sokol L, et al. Int J Hematol. 2007 Nov;86(4):301-5. doi: 10.1532/IJH97.06063. Int J Hematol. 2007. PMID: 18055335

3

Developmental therapeutics for myelodysplastic syndromes.

Naing A, Sokol L, List AF. Naing A, et al. Among authors: sokol l. J Natl Compr Canc Netw. 2006 Jan;4(1):78-82. doi: 10.6004/jnccn.2006.0008. J Natl Compr Canc Netw. 2006. PMID: 16403406 Review.

4

JAK2(V617F) mutation in myelodysplastic syndrome (MDS) with del(5q) arises in genetically discordant clones.

Sokol L, Caceres G, Rocha K, Stockero KJ, Dewald DW, List AF. Sokol L, et al. Leuk Res. 2010 Jun;34(6):821-3. doi: 10.1016/j.leukres.2009.09.016. Epub 2009 Oct 9. Leuk Res. 2010. PMID: 19819015

5

Erythropoietin receptor signaling is membrane raft dependent.

McGraw KL, Fuhler GM, Johnson JO, Clark JA, Caceres GC, Sokol L, List AF. McGraw KL, et al. Among authors: sokol l. PLoS One. 2012;7(4):e34477. doi: 10.1371/journal.pone.0034477. Epub 2012 Apr 3. PLoS One. 2012. PMID: 22509308 Free PMC article.

6

Lenalidomide induces lipid raft assembly to enhance erythropoietin receptor signaling in myelodysplastic syndrome progenitors.

McGraw KL, Basiorka AA, Johnson JO, Clark J, Caceres G, Padron E, Heaton R, Ozawa Y, Wei S, Sokol L, List AF. McGraw KL, et al. Among authors: sokol l. PLoS One. 2014 Dec 3;9(12):e114249. doi: 10.1371/journal.pone.0114249. eCollection 2014. PLoS One. 2014. PMID: 25469886 Free PMC article.

7

HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1.

Caceres G, Robey RW, Sokol L, McGraw KL, Clark J, Lawrence NJ, Sebti SM, Wiese M, List AF. Caceres G, et al. Among authors: sokol l. Cancer Res. 2012 Aug 15;72(16):4204-13. doi: 10.1158/0008-5472.CAN-12-0743. Epub 2012 Jul 3. Cancer Res. 2012. PMID: 22761337 Free PMC article.

8

Lenalidomide Stabilizes the Erythropoietin Receptor by Inhibiting the E3 Ubiquitin Ligase RNF41.

Basiorka AA, McGraw KL, De Ceuninck L, Griner LN, Zhang L, Clark JA, Caceres G, Sokol L, Komrokji RS, Reuther GW, Wei S, Tavernier J, List AF. Basiorka AA, et al. Among authors: sokol l. Cancer Res. 2016 Jun 15;76(12):3531-40. doi: 10.1158/0008-5472.CAN-15-1756. Epub 2016 Apr 6. Cancer Res. 2016. PMID: 27197154 Free PMC article.

9

Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndrome.

Sokol L, Cripe L, Kantarjian H, Sekeres MA, Parmar S, Greenberg P, Goldberg SL, Bhushan V, Shammo J, Hohl R, Verma A, Garcia-Manero G, Li YP, Lowe A, Zhu J, List AF. Sokol L, et al. Leukemia. 2013 Apr;27(4):977-80. doi: 10.1038/leu.2012.264. Epub 2012 Sep 11. Leukemia. 2013. PMID: 23032694 Clinical Trial. No abstract available.

10

Chemotherapy-related anemia.

Visweshwar N, Jaglal M, Sokol L, Zuckerman K. Visweshwar N, et al. Among authors: sokol l. Ann Hematol. 2018 Feb;97(2):375-376. doi: 10.1007/s00277-017-3155-y. Epub 2017 Nov 4. Ann Hematol. 2018. PMID: 29103107 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page